Tag: Canopy Growth

Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

On November 18, Aurora Cannabis (ACB) closed at 3 Canadian dollars on the TSX, a 16.43% drop and the third-worst trading day for it in three years.

So far, November has been tough for the cannabis sector. Most cannabis companies have reported lower-than-expected earnings.

In September, Minnesota's state legislators conducted surveys to determine public sentiment about cannabis legalization. About 55% favored legalization.

On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.

Last week, HEXO Corporation (HEXO) issued a press release that provided more information about its Niagara facility license.

Aurora Cannabis reported its third-quarter results after the market closed on November 14. Despite some positives, it fell 18% on November 15.

Cowen & Co. increased its estimates for the US cannabis market, expecting $85 billion in sales by 2030. Its previous sales forecast was $80 billion.

In today’s Get Real, we saw updates on Disney+, another round of trouble for Facebook, a potential threat to Tesla, and much more.

Cronos Group (CRON) reported its third-quarter earnings on November 12. The company missed analysts' revenue and EBITDA estimates for the quarter.